OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Nathan Kline Institute

3 Projects | 2 Researchers | $580,432 Invested

2003

Nathan Kline Institute

Suzana Petanceska, PhD

Efficacy of Oral Heparin Treatment for Alzheimer's Disease

  • Funding Amount: $98,563
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Nathan Kline Institute

Suzana Petanceska, PhD

Pharmacogenetic effects of human apoE on the amyloid-reducing activity of cholesterol lowering drugs in a transgenic mouse model for Alzheimer's disease

  • Funding Amount: $360,742
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Nathan Kline Institute

Ottavio Arancio, MD, PhD

Calpains: A Treatment of Alzheimer's Disease

  • Funding Amount: $121,127
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed